According to information procured exclusively ahead of an official announcement, the initiative, led in partnership with publicly traded cannabinoid biotech company Avicanna Inc., will make the company’s RHO Phyto product line available to Sunnybrook patients under a doctor’s prescription.
In Canada, however, regulations do allow hospitals with “appropriate infrastructure” to store and dispense certain medical cannabis products.
“This is an incredibly significant development for Avicanna as it validates our medical focus and credibility with the healthcare community.
In March, Avicanna closed a deal to license the brand of NBA star Al Harrington, Viola, and use it to create specific formulations for sale across medical and consumer retail channels in Canada.
Javier Hasse is a cannabis, hemp, CBD and psychedelics-focused reporter, currently serving as Managing Director for Benzinga Cannabis, and CEO of Spanish language news site El Planteo, a company he co-founded.